Orotracheal administration of contrast agents: a new protocol for brain tumor targeting-Reference-Cited by-同舟云学术

Orotracheal administration of contrast agents: a new protocol for brain tumor targeting

Published:2015-04-29 Issue:6 Volume:28 Page:738-746
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Bianchi Andrea¹,Moncelet Damien¹,Lux François²,Plissonneau Marie²³,Rizzitelli Silvia¹,Ribot Emeline Julie¹,Tassali Nawal¹,Bouchaud Véronique¹,Tillement Olivier²,Voisin Pierre¹,Crémillieux Yannick¹

Affiliation:

1. Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536; Université Bordeaux Segalen; Bordeaux France

2. Institut Lumière Matière, CNRS UMR 5306; Université Claude Bernard, Domaine Scientifique de La Doua; Villeurbanne France

3. Nano-H SAS; Saint-Quentin Fallavier; France

Funder

European Network PINET

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Spectroscopy,Radiology Nuclear Medicine and imaging,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nbm.3295/fullpdf

Reference52 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials;Curran;J. Natl. Cancer Inst.,1993

3. Brain tumors;De Angelis;N. Engl. J. Med.,2001

4. A view on imaging in drug research and development for respiratory diseases;Van Echteld;J. Pharmacol. Exp. Ther.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution;Clinical and Translational Radiation Oncology;2024-09

2. Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol);BMC Cancer;2023-04-15

3. Imaging drug delivery to the lungs: Methods and applications in oncology;Advanced Drug Delivery Reviews;2023-01

4. Delayed alveolar clearance of nanoparticles through control of coating composition and interaction with lung surfactant protein A;Materials Science and Engineering: C;2021-11

5. Unique features of brain metastases-targeted AGuIX nanoparticles vs their constituents: A focus on glutamate-/GABA-ergic neurotransmission in cortex nerve terminals;Food and Chemical Toxicology;2021-03